Huen Suk Kim

837 total citations
11 papers, 570 citations indexed

About

Huen Suk Kim is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Huen Suk Kim has authored 11 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Public Health, Environmental and Occupational Health and 3 papers in Oncology. Recurrent topics in Huen Suk Kim's work include Pluripotent Stem Cells Research (6 papers), Reproductive Biology and Fertility (4 papers) and Peptidase Inhibition and Analysis (3 papers). Huen Suk Kim is often cited by papers focused on Pluripotent Stem Cells Research (6 papers), Reproductive Biology and Fertility (4 papers) and Peptidase Inhibition and Analysis (3 papers). Huen Suk Kim collaborates with scholars based in United States, South Korea and Taiwan. Huen Suk Kim's co-authors include Jeffrey M. Bernitz, Hans B. Sieburg, Ben D. MacArthur, Kateri Moore, Ihor R. Lemischka, Dung‐Fang Lee, Christoph Schaniel, Henia Darr, Ye Yuan and Ruiying Zhao and has published in prestigious journals such as Cell, Journal of Medicinal Chemistry and Science Translational Medicine.

In The Last Decade

Huen Suk Kim

11 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huen Suk Kim United States 9 382 161 100 98 74 11 570
Tim Pieters Belgium 12 421 1.1× 91 0.6× 52 0.5× 78 0.8× 49 0.7× 26 563
Borko Tanasijevic Canada 14 500 1.3× 113 0.7× 40 0.4× 65 0.7× 55 0.7× 17 599
Catherine Carmichael Australia 11 277 0.7× 137 0.9× 46 0.5× 53 0.5× 54 0.7× 19 436
Simone S. Riedel United States 14 262 0.7× 132 0.8× 134 1.3× 81 0.8× 47 0.6× 30 481
Claudia Tregnago Italy 12 304 0.8× 188 1.2× 81 0.8× 41 0.4× 78 1.1× 36 483
Yusuke Nakauchi United States 10 269 0.7× 256 1.6× 122 1.2× 90 0.9× 46 0.6× 23 484
Miao-Chia Lo United States 15 560 1.5× 164 1.0× 54 0.5× 47 0.5× 60 0.8× 19 693
Bauke de Boer Netherlands 9 261 0.7× 132 0.8× 72 0.7× 67 0.7× 58 0.8× 13 394
Birte Niebuhr Germany 8 196 0.5× 138 0.9× 50 0.5× 72 0.7× 44 0.6× 10 369
María Jesús García-León Spain 13 256 0.7× 43 0.3× 144 1.4× 170 1.7× 101 1.4× 17 561

Countries citing papers authored by Huen Suk Kim

Since Specialization
Citations

This map shows the geographic impact of Huen Suk Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huen Suk Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huen Suk Kim more than expected).

Fields of papers citing papers by Huen Suk Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huen Suk Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huen Suk Kim. The network helps show where Huen Suk Kim may publish in the future.

Co-authorship network of co-authors of Huen Suk Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Huen Suk Kim. A scholar is included among the top collaborators of Huen Suk Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huen Suk Kim. Huen Suk Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Sun, Renhong, Zhongli Xu, Huen Suk Kim, et al.. (2025). Discovery of the first-in-class DOT1L PROTAC degrader. European Journal of Medicinal Chemistry. 291. 117595–117595. 2 indexed citations
2.
Yu, Xufen, Dongxu Li, Jithesh Kottur, et al.. (2023). Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer. Journal of Medicinal Chemistry. 66(23). 16168–16186. 17 indexed citations
3.
Yu, Xufen, Jithesh Kottur, Yudao Shen, et al.. (2021). A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models. Science Translational Medicine. 13(613). eabj1578–eabj1578. 91 indexed citations
4.
Bernitz, Jeffrey M., Huen Suk Kim, Ben D. MacArthur, Hans B. Sieburg, & Kateri Moore. (2016). Hematopoietic Stem Cells Count and Remember Self-Renewal Divisions. Cell. 167(5). 1296–1309.e10. 184 indexed citations
5.
Lee, Dung‐Fang, Jie Su, Huen Suk Kim, et al.. (2015). Modeling Familial Cancer with Induced Pluripotent Stem Cells. Cell. 161(2). 240–254. 169 indexed citations
6.
Kim, Huen Suk, Jeffrey M. Bernitz, Dung‐Fang Lee, & Ihor R. Lemischka. (2014). Genomic Editing Tools to Model Human Diseases with Isogenic Pluripotent Stem Cells. Stem Cells and Development. 23(22). 2673–2686. 42 indexed citations
7.
Park, Chi‐Hun, Huen Suk Kim, Yeon Woo Jeong, et al.. (2013). Effects of Trichostatin A on <italic>In vitro</italic> Development of Porcine Embryos Derived from Somatic Cell Nuclear Transfer. Asian-Australasian Journal of Animal Sciences. 26(12). 1680–1688. 9 indexed citations
8.
Kim, Huen Suk, et al.. (2011). Effects of Repetitive Ionomycin Treatment on <i>In Vitro</i> Development of Bovine Somatic Cell Nuclear Transfer Embryos. Journal of Reproduction and Development. 58(1). 132–139. 8 indexed citations
9.
Kim, Huen Suk, et al.. (2010). Effects of Recombinant Relaxin on In Vitro Maturation of Porcine Oocytes. Journal of Veterinary Medical Science. 72(3). 333–337. 13 indexed citations
10.
Hossein, Mohammad Shamim, Yeon Woo Jeong, Sun Woo Park, et al.. (2009). Cloning Missy: Obtaining Multiple Offspring of a Specific Canine Genotype by Somatic Cell Nuclear Transfer. Cloning and Stem Cells. 11(1). 123–130. 22 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tim Pieters Breakdown of academic impact, for papers by Borko Tanasijevic Breakdown of academic impact, for papers by Catherine Carmichael Breakdown of academic impact, for papers by Simone S. Riedel Breakdown of academic impact, for papers by Claudia Tregnago Breakdown of academic impact, for papers by Yusuke Nakauchi Breakdown of academic impact, for papers by Miao-Chia Lo Breakdown of academic impact, for papers by Bauke de Boer Breakdown of academic impact, for papers by Birte Niebuhr Breakdown of academic impact, for papers by María Jesús García-León
Rankless by CCL
2026